MAINTENANCE OF LEBRIKIZUMAB EFFICACY IN MODERATE-TO-SEVERE ATOPIC DERMATITIS PATIENTS WITH STABLE ASTHMA CONTROL

被引：0
|
作者：
Mehta, V.
Worm, M.
Chiesa, Z.
Natalie, C.
Dawson, Z.
Zhong, J.
Diemert, S.
Boguniewicz, M.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2023年 / 131卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P280
引用
收藏
页码：S89 / S90
页数：2
相关论文
共 50 条
  • [41] Lebrikizumab Combined with Topical Corticosteroids Improves Patient- reported Outcomes in Japanese Patients with Moderate-to-severe Atopic Dermatitis
    Tanaka, Akio
    Igawa, Ken
    Takahashi, Hidetoshi
    Shimizu, Ryosuke
    Kataoka, Yoko
    Torisu-Itakura, Hitoe
    Morisaki, Yoji
    Montmayeur, Sonia
    Katoh, Norito
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [42] Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial (ADhere)
    Simpson, Eric L. L.
    Gooderham, Melinda
    Wollenberg, Andreas
    Weidinger, Stephan
    Armstrong, April
    Soung, Jennifer
    Ferrucci, Silvia
    Lima, Renata Gontijo
    Witte, Michael M. M.
    Xu, Wen
    ElMaraghy, Hany
    Natalie, Chitra R. R.
    Pierce, Evangeline
    Blauvelt, Andrew
    ADhere Investigators
    JAMA DERMATOLOGY, 2023, 159 (02) : 182 - 191
  • [43] The efficacy and immunological effects of upadacitinib in the treatment of moderate-to-severe Chinese atopic dermatitis patients
    Li, Lu
    Wu, Naming
    Liu, Tingyu
    Yu, Guoqun
    Wang, Yifei
    He, Ting
    Mao, Raymond
    Yang, Liu
    Li, Yan
    Shen, Chen
    Tao, Juan
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 125
  • [44] Efficacy and Safety of Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial
    Silverberg, Jonathan, I
    Simpson, Eric L.
    Thyssen, Jacob P.
    Gooderham, Melinda
    Chan, Gary
    Feeney, Claire
    Biswas, Pinaki
    Valdez, Hernan
    DiBonaventura, Marco
    Nduaka, Chudy
    Rojo, Ricardo
    JAMA DERMATOLOGY, 2020, 156 (08) : 863 - 873
  • [45] Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
    Gold, Linda Stein
    Thaci, Diamant
    Thyssen, Jacob P.
    Gooderham, Melinda
    Laquer, Vivian
    Moore, Angela
    Natalie, Chitra R.
    Zhao, Fangyi
    Meskimen, Eric
    Elmaraghy, Hany
    Montmayeur, Sonia
    Gallo, Gaia
    Jimenez, Gemma
    de Bruin-Weller, Marjolein
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (04) : 595 - 607
  • [46] Patients with Moderate-to-Severe Atopic Dermatitis Maintain Stable Response with No or Minimal Fluctuations with 1 Year of Lebrikizumab Treatment (vol 14, pg 2249, 2024)
    Silverberg, Jonathan I.
    Wollenberg, Andreas
    Stein Gold, Linda
    Del Rosso, James
    Yosipovitch, Gil
    Lio, Peter
    Carrascosa, Jose-Manuel
    Gallo, Gaia
    Ding, Yuxin
    Xu, Zhenhui
    Casillas, Marta
    Pierce, Evangeline
    Agell, Helena
    Staender, Sonja
    DERMATOLOGY AND THERAPY, 2024, 14 (11) : 3195 - 3196
  • [47] Efficacy and safety of dupilumab for the treatment of moderate-to-severe atopic dermatitis in adults
    Zheng, Y.
    BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 : 72 - 72
  • [48] Efficacy and safety of ustekinumab treatment in adults with moderate-to-severe atopic dermatitis
    Khattri, Saakshi
    Brunner, Patrick M.
    Garcet, Sandra
    Finney, Robert
    Cohen, Steven R.
    Oliva, Margeaux
    Dutt, Riana
    Fuentes-Duculan, Judilyn
    Zheng, Xiuzhong
    Li, Xuan
    Bonifacio, Kathleen M.
    Kunjravia, Norma
    Coats, Israel
    Cueto, Inna
    Gilleaudeau, Patricia
    Sullivan-Whalen, Mary
    Suarez-Farinas, Mayte
    Krueger, James G.
    Guttman-Yassky, Emma
    EXPERIMENTAL DERMATOLOGY, 2017, 26 (01) : 28 - 35
  • [49] Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials
    Linda Stein Gold
    Diamant Thaçi
    Jacob P. Thyssen
    Melinda Gooderham
    Vivian Laquer
    Angela Moore
    Chitra R. Natalie
    Fangyi Zhao
    Eric Meskimen
    Hany Elmaraghy
    Sonia Montmayeur
    Gaia Gallo
    Gemma Jimenez
    Marjolein de Bruin-Weller
    American Journal of Clinical Dermatology, 2023, 24 : 595 - 607
  • [50] Evaluating the safety and efficacy of baricitinib for the treatment of moderate-to-severe atopic dermatitis
    Bridgeman, Sarah G.
    Martino, Anna K.
    Strowd, Lindsay C.
    EXPERT OPINION ON PHARMACOTHERAPY, 2023, 24 (18) : 2153 - 2159
12345